Logo image of CRS

CARPENTER TECHNOLOGY (CRS) Stock Fundamental Analysis

USA - NYSE:CRS - US1442851036 - Common Stock

243.93 USD
+1.76 (+0.73%)
Last: 10/15/2025, 2:00:17 PM
Fundamental Rating

6

Overall CRS gets a fundamental rating of 6 out of 10. We evaluated CRS against 156 industry peers in the Metals & Mining industry. CRS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRS is not valued too expensively and it also shows a decent growth rate. These ratings could make CRS a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CRS had positive earnings in the past year.
CRS had a positive operating cash flow in the past year.
In multiple years CRS reported negative net income over the last 5 years.
In the past 5 years CRS always reported a positive cash flow from operatings.
CRS Yearly Net Income VS EBIT VS OCF VS FCFCRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.77%, CRS belongs to the top of the industry, outperforming 91.03% of the companies in the same industry.
CRS's Return On Equity of 19.91% is amongst the best of the industry. CRS outperforms 93.59% of its industry peers.
CRS has a Return On Invested Capital of 14.75%. This is amongst the best in the industry. CRS outperforms 93.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRS is below the industry average of 12.18%.
The 3 year average ROIC (9.88%) for CRS is below the current ROIC(14.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.77%
ROE 19.91%
ROIC 14.75%
ROA(3y)6.09%
ROA(5y)1.77%
ROE(3y)11.79%
ROE(5y)3.03%
ROIC(3y)9.88%
ROIC(5y)N/A
CRS Yearly ROA, ROE, ROICCRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

CRS has a Profit Margin of 13.06%. This is in the better half of the industry: CRS outperforms 77.56% of its industry peers.
In the last couple of years the Profit Margin of CRS has grown nicely.
With a decent Operating Margin value of 18.26%, CRS is doing good in the industry, outperforming 71.15% of the companies in the same industry.
CRS's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 26.71%, CRS is doing good in the industry, outperforming 64.74% of the companies in the same industry.
CRS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.26%
PM (TTM) 13.06%
GM 26.71%
OM growth 3YN/A
OM growth 5Y20.36%
PM growth 3YN/A
PM growth 5Y203.85%
GM growth 3Y48.5%
GM growth 5Y10.19%
CRS Yearly Profit, Operating, Gross MarginsCRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

7

2. Health

2.1 Basic Checks

CRS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRS has about the same amount of shares outstanding.
The number of shares outstanding for CRS has been increased compared to 5 years ago.
The debt/assets ratio for CRS has been reduced compared to a year ago.
CRS Yearly Shares OutstandingCRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRS Yearly Total Debt VS Total AssetsCRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

An Altman-Z score of 6.98 indicates that CRS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.98, CRS is in the better half of the industry, outperforming 69.87% of the companies in the same industry.
The Debt to FCF ratio of CRS is 2.43, which is a good value as it means it would take CRS, 2.43 years of fcf income to pay off all of its debts.
CRS has a Debt to FCF ratio of 2.43. This is in the better half of the industry: CRS outperforms 78.21% of its industry peers.
CRS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
CRS has a worse Debt to Equity ratio (0.37) than 69.87% of its industry peers.
Even though the debt/equity ratio score it not favorable for CRS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 2.43
Altman-Z 6.98
ROIC/WACC1.55
WACC9.54%
CRS Yearly LT Debt VS Equity VS FCFCRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.65 indicates that CRS has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.65, CRS is doing good in the industry, outperforming 69.87% of the companies in the same industry.
CRS has a Quick Ratio of 2.01. This indicates that CRS is financially healthy and has no problem in meeting its short term obligations.
CRS has a Quick ratio (2.01) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.65
Quick Ratio 2.01
CRS Yearly Current Assets VS Current LiabilitesCRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.47% over the past year.
The Earnings Per Share has been growing by 27.85% on average over the past years. This is a very strong growth
Looking at the last year, CRS shows a small growth in Revenue. The Revenue has grown by 4.26% in the last year.
The Revenue has been growing slightly by 5.70% on average over the past years.
EPS 1Y (TTM)57.47%
EPS 3YN/A
EPS 5Y27.85%
EPS Q2Q%21.43%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y16.15%
Revenue growth 5Y5.7%
Sales Q2Q%-5.4%

3.2 Future

The Earnings Per Share is expected to grow by 14.22% on average over the next years. This is quite good.
CRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.85% yearly.
EPS Next Y32.39%
EPS Next 2Y26.69%
EPS Next 3Y21.24%
EPS Next 5Y14.22%
Revenue Next Year7.44%
Revenue Next 2Y8.67%
Revenue Next 3Y7.09%
Revenue Next 5Y5.85%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRS Yearly Revenue VS EstimatesCRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CRS Yearly EPS VS EstimatesCRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.61, CRS can be considered very expensive at the moment.
68.59% of the companies in the same industry are more expensive than CRS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.49. CRS is around the same levels.
The Price/Forward Earnings ratio is 24.63, which indicates a rather expensive current valuation of CRS.
CRS's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.99. CRS is around the same levels.
Industry RankSector Rank
PE 32.61
Fwd PE 24.63
CRS Price Earnings VS Forward Price EarningsCRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRS is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CRS is valued a bit cheaper than 69.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.5
EV/EBITDA 18.74
CRS Per share dataCRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CRS may justify a higher PE ratio.
CRS's earnings are expected to grow with 21.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.01
PEG (5Y)1.17
EPS Next 2Y26.69%
EPS Next 3Y21.24%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.32%, CRS is not a good candidate for dividend investing.
CRS's Dividend Yield is a higher than the industry average which is at 2.41.
Compared to an average S&P500 Dividend Yield of 2.43, CRS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

The dividend of CRS decreases each year by -0.08%.
CRS has been paying a dividend for at least 10 years, so it has a reliable track record.
CRS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.08%
Div Incr Years0
Div Non Decr Years21
CRS Yearly Dividends per shareCRS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

10.73% of the earnings are spent on dividend by CRS. This is a low number and sustainable payout ratio.
DP10.73%
EPS Next 2Y26.69%
EPS Next 3Y21.24%
CRS Yearly Income VS Free CF VS DividendCRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M
CRS Dividend Payout.CRS Dividend Payout, showing the Payout Ratio.CRS Dividend Payout.PayoutRetained Earnings

CARPENTER TECHNOLOGY

NYSE:CRS (10/15/2025, 2:00:17 PM)

243.93

+1.76 (+0.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners98.01%
Inst Owner Change-0.36%
Ins Owners2.37%
Ins Owner Change4.56%
Market Cap12.16B
Analysts80
Price Target300.61 (23.24%)
Short Float %6.45%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.81
Dividend Growth(5Y)-0.08%
DP10.73%
Div Incr Years0
Div Non Decr Years21
Ex-Date08-26 2025-08-26 (0.2)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.55%
Min EPS beat(2)5.81%
Max EPS beat(2)7.28%
EPS beat(4)4
Avg EPS beat(4)5.93%
Min EPS beat(4)2.34%
Max EPS beat(4)8.27%
EPS beat(8)7
Avg EPS beat(8)10.46%
EPS beat(12)11
Avg EPS beat(12)10.85%
EPS beat(16)15
Avg EPS beat(16)17.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.49%
Min Revenue beat(2)-5.61%
Max Revenue beat(2)-1.38%
Revenue beat(4)0
Avg Revenue beat(4)-4.6%
Min Revenue beat(4)-7.04%
Max Revenue beat(4)-1.38%
Revenue beat(8)1
Avg Revenue beat(8)-4.71%
Revenue beat(12)4
Avg Revenue beat(12)-2.21%
Revenue beat(16)7
Avg Revenue beat(16)-0.21%
PT rev (1m)1.42%
PT rev (3m)10.8%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)7.16%
EPS NY rev (1m)0%
EPS NY rev (3m)5.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.45%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 32.61
Fwd PE 24.63
P/S 4.23
P/FCF 42.5
P/OCF 27.61
P/B 6.44
P/tB 7.37
EV/EBITDA 18.74
EPS(TTM)7.48
EY3.07%
EPS(NY)9.9
Fwd EY4.06%
FCF(TTM)5.74
FCFY2.35%
OCF(TTM)8.83
OCFY3.62%
SpS57.72
BVpS37.85
TBVpS33.1
PEG (NY)1.01
PEG (5Y)1.17
Profitability
Industry RankSector Rank
ROA 10.77%
ROE 19.91%
ROCE 17.49%
ROIC 14.75%
ROICexc 16.48%
ROICexgc 18.07%
OM 18.26%
PM (TTM) 13.06%
GM 26.71%
FCFM 9.94%
ROA(3y)6.09%
ROA(5y)1.77%
ROE(3y)11.79%
ROE(5y)3.03%
ROIC(3y)9.88%
ROIC(5y)N/A
ROICexc(3y)10.75%
ROICexc(5y)N/A
ROICexgc(3y)11.84%
ROICexgc(5y)N/A
ROCE(3y)11.72%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.78%
ROICexc growth 3YN/A
ROICexc growth 5Y27.82%
OM growth 3YN/A
OM growth 5Y20.36%
PM growth 3YN/A
PM growth 5Y203.85%
GM growth 3Y48.5%
GM growth 5Y10.19%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 2.43
Debt/EBITDA 1.05
Cap/Depr 110.85%
Cap/Sales 5.36%
Interest Coverage 10.85
Cash Conversion 66.28%
Profit Quality 76.15%
Current Ratio 3.65
Quick Ratio 2.01
Altman-Z 6.98
F-Score8
WACC9.54%
ROIC/WACC1.55
Cap/Depr(3y)81.81%
Cap/Depr(5y)79.25%
Cap/Sales(3y)4.03%
Cap/Sales(5y)4.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.47%
EPS 3YN/A
EPS 5Y27.85%
EPS Q2Q%21.43%
EPS Next Y32.39%
EPS Next 2Y26.69%
EPS Next 3Y21.24%
EPS Next 5Y14.22%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y16.15%
Revenue growth 5Y5.7%
Sales Q2Q%-5.4%
Revenue Next Year7.44%
Revenue Next 2Y8.67%
Revenue Next 3Y7.09%
Revenue Next 5Y5.85%
EBIT growth 1Y48.39%
EBIT growth 3YN/A
EBIT growth 5Y27.21%
EBIT Next Year59.09%
EBIT Next 3Y29.51%
EBIT Next 5Y26.52%
FCF growth 1Y60.46%
FCF growth 3YN/A
FCF growth 5Y36.49%
OCF growth 1Y60.2%
OCF growth 3Y318.7%
OCF growth 5Y13.7%